Small Caps

From AIM listing to being bought by Mars: the Hotel Chocolat journey

A plain-English guide to aim listing bought by, using a small-cap case study to show what careful UK readers should check before trusting the headline.

By Cameron Oliver · June 19, 2026

Reviewed by Sarah Okafor, Editor · June 19, 2026, 09:32

From AIM listing to being bought by Mars: the Hotel Chocolat journey shows how a loved AIM brand became a patient-capital exit story.

In this article

The Short Version

Hotel Chocolat listed on AIM and later agreed a cash offer from Mars.
The offer price was 375p per share, according to the official announcement.
The deal valued the equity at £534 million and the enterprise at £570 million.
The story rewards patient reading, not hindsight triumph.

A different kind of small-cap story

Hotel Chocolat was not a tale of sudden overnight luck. It was a long public-market story with a private-market ending. The company had a brand many shoppers recognised. Its shareholders still lived with the share price cycle.

That makes the Mars deal worth studying with care. It was positive, but not simple. A strong exit can arrive after a hard fall. The full record matters more than the headline premium.

The build

Hotel Chocolat joined AIM on 10 May 2016 at 148p per share, with a £167 million market capitalisation. That gave public investors access to a growing consumer brand. The shares later traded well above the admission price. The brand had real reach beyond the stock market.

For small-cap investors, that first stage can feel exciting. A known brand makes the story easier to understand. A public quote also makes every wobble visible. That visibility can test patience before the ending arrives.

The crash

By early 2022, the shares had traded above 500p. The later offer did not erase that earlier high. It created a settled exit after a difficult period. That distinction keeps the case grounded.

A positive exit can still contain pain. Some holders may have bought near better prices. Others may have entered much earlier. Each entry point changes how the same bid feels.

The bid arrives

On 16 November 2023, Mars moved from admirer to bidder. The London Stock Exchange RNS: Recommended cash acquisition of Hotel Chocolat set out the cash terms. Hive Bidco, an indirect Mars subsidiary, offered 375p for each share. That gave holders a defined price and a defined route out.

The offer represented about 170% to the 139p close on 15 November 2023. The announcement gave a stated equity value of £534 million. It also gave a stated enterprise value of £570 million. Those figures belong at the centre of the story.

The mechanics

A bid only becomes real for ordinary holders through the timetable. Here, the public record gives that timetable. The scheme became effective on 25 January 2024. AIM cancellation followed on 26 January 2024 at 7:00am.

The director support also mattered. The announcement said directors holding about 54 percent committed to vote in favour. That did not make the deal automatic. It did show why the timetable had weight.

Reference point	Verified fact	What it shows
AIM admission.	10 May 2016 at 148p per share, with a £167 million market capitalisation.	The public story began below the later offer price.
Early 2022 level.	Above 500p.	Some holders saw a much higher market price before the deal.
Cash offer.	375p per share.	The exit price gave certainty after the fall.

Why the market got it wrong

The market did not price Hotel Chocolat as a certain Mars target. It priced a quoted company with public risks. The bid changed the ownership question in one announcement. That is why the premium looked so dramatic.

This is the patient-capital point. Small companies can build value away from the daily share price. A strategic buyer may value assets differently. The shareholder still needs facts before feeling vindicated.

Hotel Chocolat gives that balance in one settled case. The brand mattered. The fall mattered. The bid mechanics mattered too.